Published in:
01-02-2004 | Poster presentation
Sputum concentration of amikacin varies with nebulizer efficiency measured in vitro in patients on mechanical ventilators
Authors:
P Dequin, E Mercier, C Valat, R Fishman, J Fink, N Smith, K Gibbons, P Diot
Published in:
Critical Care
|
Special Issue 1/2004
Login to get access
Excerpt
Evaluation of the clinical utility of aerosolized antibiotics in patients with ventilator-associated pneumonia has been hampered by the inefficiency of available nebulizers. The Aerogen pulmonary drug delivery system (APD) is in development for high-efficiency lung deposition of novel therapies in mechanically ventilated patients. We compared delivery of amikacin (AMIK) via APD vs the the Aeroneb Pro (AP), and vs the AirLife™ Misty Neb™ (MN), in mechanically ventilated patients. We wanted to determine how AMIK concentrations in the sputum relate to device efficiency previously determined
in vitro [
1]. …